Capital Group Private Client Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Capital Group Private Client Services’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-131,094	Closed	-$14.3M	–	248
2023 Q1	$14.3M	Sell	131,094 -2,046	-2%	-$226K	0.18%	115
2022 Q4	$15.2M	Buy	133,140 +24,065	+22%	+$2M	0.19%	118
2022 Q3	$6.75M	Sell	109,075 -1,263	-1%	-$88.3K	0.09%	144
2022 Q2	$8.8M	Sell	110,338 -789	-0.7%	-$74.7K	0.11%	144
2022 Q1	$11.7M	Buy	+111,127	New	+$10.8M	0.13%	129

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Capital Group Private Client Services's HZNP Position: Q2 2023 in Review

Capital Group Private Client Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 131,094 shares — an estimated $14.3M sold.

Capital Group Private Client Services first reported a position in HZNP in Q1 2022 and held it in 5 quarters. The position peaked at $15.2M in Q4 2022. 517 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Capital Group Private Client Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Capital Group Private Client Services sold 131,094 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $14.3M.
Capital Group Private Client Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2022 and held it in 5 quarters.
Capital Group Private Client Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $15.2M in Q4 2022.
517 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Capital Group Private Client Services's 13F filing for Q2 2023, filed 11 Aug 2023.